echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Ed Bio and Merck have a partnership for targeted drug clinical research.

    Ed Bio and Merck have a partnership for targeted drug clinical research.

    • Last Update: 2020-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Read: Ed Bio's "Multigene Joint Detection Product for Lung Cancer" will be used in the Merck MET inhibitor Tepotinib's accompanying diagnostic registration in Japan.
    recently, Xiamen Eide Biopharmaceutical Technology Co., Ltd. and MERCK KGaA signed a cooperation agreement.
    Ed Bio's self-developed "Lung Cancer Multigene Joint Detection Product" (i.e. Ai Huijian ® Upgrade) developed on the PCR technology platform will be used for the Merck MET inhibitor Tepotinib's accompanying diagnostic registration in Japan. Tepotinib, a
    Merck MET inhibitor, was approved by Japan's Ministry of Health, Labour and Welfare in March 2020 for the treatment of non-small cell lung cancer patients with MET exon 14 jump mutation.
    Ed Bio's independent research and development of "Ai Huijian ®" (can detect multiple lung cancer core driving genes) has been approved by the State Drug Administration on August 24, 2018, this cooperation, Ai Huijian ® upgraded version has once again become Merck lung cancer target drug clinical accompanying diagnostic products, highlighting Ed Bio at home and abroad in the field of cancer diagnosis advantage swell and brand influence.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.